Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib.
Dadu R, Devine C, Hernandez M, Waguespack SG, Busaidy NL, Hu MI, Jimenez C, Habra MA, Sellin RV, Ying AK, Cote GJ, Sherman SI, Cabanillas ME.
Dadu R, et al. Among authors: hernandez m.
J Clin Endocrinol Metab. 2014 Jun;99(6):2086-94. doi: 10.1210/jc.2013-3588. Epub 2014 Mar 14.
J Clin Endocrinol Metab. 2014.
PMID: 24628550
Free PMC article.